Avivomed, Inc.
About Avivomed, Inc.
Avivomed is developing neuromodulation therapy platforms that target chronic diseases affecting large patient populations through implantable medical devices. The company addresses significant clinical needs by providing effective treatment options for conditions that currently lack adequate solutions.
```xml <problem> Many chronic diseases lack effective treatment options, leaving large patient populations with unmet clinical needs. Current therapies may be inadequate or have significant side effects, highlighting the need for innovative solutions. </problem> <solution> Avivomed is developing next-generation neuromodulation therapy platforms using implantable medical devices to address chronic diseases. These platforms aim to provide effective treatment options for conditions where current solutions are lacking. The company focuses on creating innovative therapies to improve patient outcomes and quality of life. </solution> <features> - Implantable neuromodulation devices for targeted therapy - Focus on chronic diseases with unmet clinical needs - Development of novel therapies to improve treatment effectiveness </features> <target_audience> The primary target audience includes patients suffering from chronic diseases and the physicians who treat them. </target_audience> ```
What does Avivomed, Inc. do?
Avivomed is developing neuromodulation therapy platforms that target chronic diseases affecting large patient populations through implantable medical devices. The company addresses significant clinical needs by providing effective treatment options for conditions that currently lack adequate solutions.
When was Avivomed, Inc. founded?
Avivomed, Inc. was founded in 2021.
- Founded
- 2021
- Employees
- 16 employees